Literature DB >> 17949991

Role of astrocytes and chemokine systems in acute TNFalpha induced demyelinating syndrome: CCR2-dependent signals promote astrocyte activation and survival via NF-kappaB and Akt.

Marlon P Quinones1, Yogeshwar Kalkonde, Carlos A Estrada, Fabio Jimenez, Robert Ramirez, Lenin Mahimainathan, Srinivas Mummidi, Goutam G Choudhury, Hernan Martinez, Lisa Adams, Matthias Mack, Robert L Reddick, Shivani Maffi, Sylva Haralambous, Lesley Probert, Sunil K Ahuja, Seema S Ahuja.   

Abstract

Chemotactic factors known as chemokines play an important role in the pathogenesis of multiple sclerosis (MS). Transgenic expression of TNFalpha in the central nervous system (CNS) leads to the development of a demyelinating phenotype (TNFalpha-induced demyelination; TID) that is highly reminiscent of MS. Little is known about the role of chemokines in TID but insights derived from studying this model might extend our current understanding of MS pathogenesis and complement data derived from the classic autoimmune encephalomyelitis (EAE) model system. Here we show that in TID, chemokines and their receptors were significantly increased during the acute phases of disease. Notably, the CCL2 (MCP-1)-CCR2 axis and the closely related ligand-receptor pair CCR1-CCL3 (MIP-1alpha) were among the most up-regulated during disease. On the other hand, receptors like CCR3 and CCR4 were not elevated. This significant increase in the levels of chemokines/receptors correlated with robust immune infiltration of the CNS by inflammatory cells, i.e., macrophages, and immune cells particularly T and B cells. Immunostaining and confocal microscopy, along with in vitro studies revealed that astrocytes were a major source of locally produced chemokines and expressed functional chemokine receptors such as CCR2. Using an in vitro system we demonstrate that expression of CCR2 was functional in astrocytes and that signaling via this receptor lead to activation of NF-kB and Akt and was associated with increased astrocyte survival. Collectively, our data suggests that transgenic murine models of MS are useful to dissect mechanisms of disease and that in these models, up-regulation of chemokines and their receptors may be key determinants in TID.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17949991      PMCID: PMC2894699          DOI: 10.1016/j.mcn.2007.08.017

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  49 in total

Review 1.  Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway.

Authors:  A Brunet; S R Datta; M E Greenberg
Journal:  Curr Opin Neurobiol       Date:  2001-06       Impact factor: 6.627

Review 2.  NF-kappaB in neuronal plasticity and neurodegenerative disorders.

Authors:  M P Mattson; S Camandola
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

Review 3.  The many roles of chemokines and chemokine receptors in inflammation.

Authors:  Israel F Charo; Richard M Ransohoff
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

Review 4.  Glial expression of tumor necrosis factor in transgenic animals: how do these models reflect the "normal situation"?

Authors:  L Probert; K Akassoglou
Journal:  Glia       Date:  2001-11       Impact factor: 7.452

Review 5.  Investigating chemokines and chemokine receptors in patients with multiple sclerosis: opportunities and challenges.

Authors:  C Trebst; R M Ransohoff
Journal:  Arch Neurol       Date:  2001-12

6.  Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice.

Authors:  M Mack; J Cihak; C Simonis; B Luckow; A E Proudfoot; J Plachý ; H Brühl; M Frink; H J Anders; V Vielhauer; J Pfirstinger; M Stangassinger; D Schlöndorff
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

7.  Activation-induced cell death of rat astrocytes.

Authors:  K Suk; J Lee; J Hur; Y S Kim; M Lee; S Cha; S Yeou Kim; H Kim
Journal:  Brain Res       Date:  2001-05-11       Impact factor: 3.252

8.  Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2.

Authors:  L Izikson; R S Klein; I F Charo; H L Weiner; A D Luster
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

9.  Preformed membrane-associated stores of interleukin (IL)-12 are a previously unrecognized source of bioactive IL-12 that is mobilized within minutes of contact with an intracellular parasite.

Authors:  M Quinones; S K Ahuja; P C Melby; L Pate; R L Reddick; S S Ahuja
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

10.  Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis.

Authors:  D R Huang; J Wang; P Kivisakk; B J Rollins; R M Ransohoff
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

View more
  25 in total

Review 1.  Control of autoimmune CNS inflammation by astrocytes.

Authors:  Veit Rothhammer; Francisco J Quintana
Journal:  Semin Immunopathol       Date:  2015-07-30       Impact factor: 9.623

2.  Absence of CCL2 and CCL3 Ameliorates Central Nervous System Grey Matter But Not White Matter Demyelination in the Presence of an Intact Blood-Brain Barrier.

Authors:  Katharina Janssen; Mira Rickert; Tim Clarner; Cordian Beyer; Markus Kipp
Journal:  Mol Neurobiol       Date:  2015-02-08       Impact factor: 5.590

3.  Involvement of spinal chemokine CCL2 in the hyperalgesia evoked by bone cancer in mice: a role for astroglia and microglia.

Authors:  Marta Pevida; Sara González-Rodríguez; Ana Lastra; Olivia García-Suárez; Agustín Hidalgo; Luis Menéndez; Ana Baamonde
Journal:  Cell Mol Neurobiol       Date:  2014-01       Impact factor: 5.046

4.  CXCL16 orchestrates adenosine A3 receptor and MCP-1/CCL2 activity to protect neurons from excitotoxic cell death in the CNS.

Authors:  Maria Rosito; Cristina Deflorio; Cristina Limatola; Flavia Trettel
Journal:  J Neurosci       Date:  2012-02-29       Impact factor: 6.167

Review 5.  Monocyte chemoattractant protein-1 and the blood-brain barrier.

Authors:  Yao Yao; Stella E Tsirka
Journal:  Cell Mol Life Sci       Date:  2013-09-20       Impact factor: 9.261

6.  Astroglial NF-κB mediates oxidative stress by regulation of NADPH oxidase in a model of retinal ischemia reperfusion injury.

Authors:  David J Barakat; Galina Dvoriantchikova; Dmitry Ivanov; Valery I Shestopalov
Journal:  J Neurochem       Date:  2012-01-04       Impact factor: 5.372

7.  Kit (W-sh) mice develop earlier and more severe experimental autoimmune encephalomyelitis due to absence of immune suppression.

Authors:  Hongmei Li; Bardia Nourbakhsh; Farinaz Safavi; Ke Li; Hui Xu; Melissa Cullimore; Fang Zhou; Guangxian Zhang; Abdolmohamad Rostami
Journal:  J Immunol       Date:  2011-06-06       Impact factor: 5.422

8.  Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats.

Authors:  Arabinda Das; M Kelly Guyton; Amena Smith; Gerald Wallace; Misty L McDowell; Denise D Matzelle; Swapan K Ray; Naren L Banik
Journal:  J Neurochem       Date:  2012-11-22       Impact factor: 5.372

9.  Chemokine CCL2 and its receptor CCR2 are increased in the hippocampus following pilocarpine-induced status epilepticus.

Authors:  Maira L Foresti; Gabriel M Arisi; Khurshed Katki; Andres Montañez; Russell M Sanchez; Lee A Shapiro
Journal:  J Neuroinflammation       Date:  2009-12-24       Impact factor: 8.322

10.  Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype.

Authors:  George P Christophi; Michael Panos; Chad A Hudson; Rebecca L Christophi; Ross C Gruber; Akos T Mersich; Scott D Blystone; Burk Jubelt; Paul T Massa
Journal:  Lab Invest       Date:  2009-04-27       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.